Bluebird bio Inc (NASDAQ: BLUE) on Monday, plunged -1.36% from the previous trading day, before settling in for the closing price of $0.46. Within the past 52 weeks, BLUE’s price has moved between $0.29 and $5.53.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 120.02% over the last five years. The company achieved an average annual earnings per share of 19.23%. With a float of $192.72 million, this company’s outstanding shares have now reached $193.92 million.
The firm has a total of 375 workers. Let’s measure their productivity. In terms of profitability, gross margin is -43.49%, operating margin of -596.15%, and the pretax margin is -565.89%.
Bluebird bio Inc (BLUE) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Bluebird bio Inc is 0.89%, while institutional ownership is 34.11%. The most recent insider transaction that took place on Sep 30 ’24, was worth 529. In this transaction an insider of this company sold 1,006 shares at a rate of $0.53, taking the stock ownership to the 170,000 shares. Before that another transaction happened on Sep 30 ’24, when Company’s President and CEO sold 34,780 for $0.53, making the entire transaction worth $18,270. This insider now owns 375,218 shares in total.
Bluebird bio Inc (BLUE) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.18 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 19.23% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 45.80% during the next five years compared to 28.98% growth over the previous five years of trading.
Bluebird bio Inc (NASDAQ: BLUE) Trading Performance Indicators
Bluebird bio Inc (BLUE) is currently performing well based on its current performance indicators. A quick ratio of 0.33 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.80, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -0.53 in one year’s time.
Technical Analysis of Bluebird bio Inc (BLUE)
Analysing the last 5-days average volume posted by the [Bluebird bio Inc, BLUE], we can find that recorded value of 26.8 million was better than the volume posted last year of 7.76 million. As of the previous 9 days, the stock’s Stochastic %D was 26.85%. Additionally, its Average True Range was 0.08.
During the past 100 days, Bluebird bio Inc’s (BLUE) raw stochastic average was set at 16.48%, which indicates a significant decrease from 33.13% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 387.08% in the past 14 days, which was higher than the 170.93% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4475, while its 200-day Moving Average is $0.8623. Now, the first resistance to watch is $0.4960. This is followed by the second major resistance level at $0.5429. The third major resistance level sits at $0.5754. If the price goes on to break the first support level at $0.4166, it is likely to go to the next support level at $0.3841. Now, if the price goes above the second support level, the third support stands at $0.3372.
Bluebird bio Inc (NASDAQ: BLUE) Key Stats
Market capitalization of the company is 87.31 million based on 194,444K outstanding shares. Right now, sales total 29,500 K and income totals -211,910 K. The company made 10,610 K in profit during its latest quarter, and -60,810 K in sales during its previous quarter.
